Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus), includes multiplex reverse transcription, when perfor
CPT4 code
Name of the Procedure:
Infectious Agent Detection by Nucleic Acid (DNA or RNA) for Respiratory Viruses
Common Names: Multiplex RT-PCR for Respiratory Viruses, Respiratory Virus Panel Test
Summary
This diagnostic test detects the genetic material (DNA or RNA) of respiratory viruses such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, and rhinovirus in a patient's respiratory sample. The test uses a technique called multiplex reverse transcription polymerase chain reaction (RT-PCR) to identify multiple viruses in one go.
Purpose
This test is used to diagnose respiratory infections caused by various viruses. The goal is to identify the specific virus responsible for symptoms like fever, cough, sore throat, and shortness of breath, which helps guide appropriate treatment and management.
Indications
- Symptoms such as fever, cough, stuffy or runny nose, sore throat, and difficulty breathing.
- Suspected respiratory infection, especially during flu season or outbreaks.
- Hospitalized patients with severe respiratory symptoms.
- Immunocompromised patients or those with chronic respiratory conditions showing worsening symptoms.
Preparation
- No special preparation is typically required.
- Patients may be asked to provide a sample through a swab of the nose or throat.
Procedure Description
- A healthcare provider collects a respiratory sample using a swab inserted into the nose or throat.
- The sample is sent to a lab, where viral nucleic acids are extracted.
- Reverse transcription converts viral RNA into DNA if RNA viruses are present.
- Multiple PCR reactions are performed simultaneously (multiplex), amplifying specific DNA sequences of different respiratory viruses.
- Results indicate the presence or absence of specific viral pathogens.
Duration
The sample collection takes a few minutes. Lab processing generally takes a few hours to a few days, depending on the lab's workload and protocols.
Setting
- Hospital labs
- Outpatient clinics
- Diagnostic laboratories
Personnel
- Healthcare provider (nurse or technician) for sample collection
- Laboratory technicians and molecular biologists for processing and analyzing the sample
Risks and Complications
- Minor discomfort or gagging during sample collection
- Rarely, slight bleeding or irritation at the sample collection site
Benefits
- Rapid and accurate identification of the causative virus
- Enables timely and appropriate treatment
- Helps prevent the spread of the virus by implementing appropriate infection control measures
Recovery
- No recovery needed from the test itself
- Follow-up depends on the test results and the patient's condition, potentially including antiviral treatments or other therapies.
Alternatives
- Rapid antigen tests: Faster but less sensitive and specific.
- Viral cultures: More accurate but significantly longer turnaround time.
- Serological tests: Useful for detecting antibodies but not for early diagnosis.
Patient Experience
- Patients may experience brief discomfort during the swab collection.
- No significant pain is expected.
- Results can provide relief by identifying the specific cause of symptoms, aiding in proper management.
Pain management and comfort measures: Gentle swab techniques and patient reassurance during the sample collection process.